Showing 17–22 of 22 results

  • JTE-907 for Research and Analytical Applications

    JTE-907 for Research and Analytical Applications

    JTE-907 for Research and Analytical Applications in the USA and Kazakhstan JTE-907 is a synthetic research compound studied in controlled laboratory environments for its interaction with cannabinoid receptor systems, particularly within pharmacological and biochemical research. It is commonly referenced in scientific investigations involving receptor binding, molecular pathways, and analytical compound behavior. Because of its specialized…

  • MDA-19

    MDA-19

    MDA-19 is a synthetic drug, a selective agonist of the cannabinoid receptor CB2 and CB1, with some changes between these species. MDA-19 is designed to treat neuropathic pain and has been tested on animals, does not produce cannabis behavioral effects. You can buy MDA-19 online right now from our manager as a designer drug for chemical…

  • MMB-FUBINACA

    MMB-FUBINACA

    MMB-FUBINACA (MMB-FUB, FUB-AMB) is a new indazole-based synthetic cannabinoid developed as a replacement for AB-FUBINACA and has a similar structure and properties. This drug can affect and activate CB1 and CB2 receptors. MMB-FUBINACA is marketed as a designer drug and little is known about its dosages and properties. This drug is prohibited for sale in…

  • NM-2-AI (N-methyl-2-aminoindane)

    NM-2-AI (N-methyl-2-aminoindane)

    N-methyl-2-aminoindane(also called NM-2-AI) It is a stimulant drug of the aminoindane class, an N-methylated derivative of 2-aminoindane, a structural analogue of MDAI and 2-AI and has similar properties and causes similar effects, but has a lower potency and has a longer duration. NM2-AI acts as an agent releasing dopamine and norepinephrine, it increases the level…

  • SGT-152 (CUMYL-NBMINACA)

    SGT-152 (CUMYL-NBMINACA)

    SGT-152 (CUMYL-NBMINACA) is a synthetic cannabinoid of cumyl subgroup, a structural analogue and active isomer of CUMYL-NBMICA, is a strong agonist of cannabinoid receptors and has a similar effect. This designer drug has been little studied and is intended for research in laboratory conditions. This drug is still quite new and is available for sale…

  • SGT-280

    SGT-280

    CUMYL-CBMICA or SGT-280 is an indoles-class designer cannabinoid, a strong CB1 cannabinoid receptor agonist. Structurally, SGT-280 belongs to the indoles class and is synthesized on the basis of indole-3-carboxamide. This drug is prohibited for sale in the UK and Germany. This drug is synthesized in a special laboratory by professional chemists, which makes this drug…